CARL VANSELOW: Open Payments
NPI 1730186198 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 11 payments from 9 companies in 2025. Trend: 2023 $340 · 2024 $556 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK INC. | 1 | $107 |
| Novo Nordisk Inc | 2 | $40 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: BIOMONITOR, Wegovy, LifeVest, LEQVIO, JARDIANCE, JUXTAPID, Repatha, Adempas.
Industry payments across AZ — which companies pay providers there.
